Okay. We have everybody's approval.
(Motion agreed to)
One other thing is that we did receive a joint written brief from Professor Dupras and Professor Parent on the WTO study. It came in after the deadline. It was distributed to all of the members. Is it the will of the committee to accept that brief that came in slightly late, since we have not started consideration of the draft report?
I do not see any objections. I appreciate that.
Pursuant to Standing Order 108, and the motion adopted by the committee on March 12, 2021, the committee will proceed with its study of Canada's international trade and investment policy regarding selected considerations concerning COVID-19 vaccines.
I'd like to introduce our witnesses today.
From England, as an individual, we have Simon Evenett, professor at the University of St. Gallen. From the United States, on behalf of the Center for Global Development, Rachel Silverman, policy fellow; and Prashant Yadav, senior fellow. From Canada, on behalf of Innovative Medicines Canada, Pamela Fralick, president; and Declan Hamill, vice-president, legal, regulatory affairs and compliance. From Intellectual Property Institute of Canada, Nathaniel Lipkus, past board member, intellectual property lawyer and patent agent.
Professor Evenett, you have the floor, please.